AnaptysBio downgraded to Neutral from Buy at BTIG
BTIG downgraded AnaptysBio (ANAB) to Neutral from Buy without a price target The company’s topline data from the Phase 2b trial of ANB032 in ...
Ciena’s Hold Rating: Balancing Growth Opportunities and Macroeconomic Challenges
Samik Chatterjee, an analyst from J.P. Morgan, maintained the Hold rating on Ciena (CIEN – Research Report). The associated price target ...